Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Businessweek Archives

To Cyanamid, A Buck Made The Difference


In Business This Week

TO CYANAMID, A BUCK MADE THE DIFFERENCE

One hundred dollars a share didn't quite cut it. At $101, though, American Home Products had a deal. On Aug. 17, after two weeks of resisting, American Cyanamid finally accepted AHP's revised $9.6 billion merger offer--one day after a deadline for the slightly less generous bid had expired. The annual revenues of the combined drug, chemical, and consumer-health-product giant will be more than $12 billion. AHP's expensive chase helped lift depressed drug stocks generally. The biggest gainer was Eli Lilly, whose shares jumped 9% in just two days on rumors that Britain's Glaxo Holdings was pondering a takeover attempt. Some analysts say investors are overreacting, given Lilly's weak development pipeline. Neither company would comment.EDITED BY KEITH H. HAMMONDS


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus